misonidazole has been researched along with Experimental Mammary Neoplasms in 72 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 55 (76.39) | 18.7374 |
1990's | 12 (16.67) | 18.2507 |
2000's | 4 (5.56) | 29.6817 |
2010's | 1 (1.39) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denny, WA; Hay, MP; Lee, HH; Roberts, PB; Wilson, WR | 1 |
Ayers, GD; Fluckiger, JU; Peterson, TE; Tantawy, MN; Whisenant, JG; Yankeelov, TE | 1 |
Bentzen, L; Grönroos, T; Hansen, SB; Horsman, MR; Keiding, S; Overgaard, J | 1 |
Bentzen, L; Eskola, O; Grönroos, T; Haaparanta, M; Horsman, MR; Keiding, S; Marjamäki, P; Minn, H; Murata, R; Solin, O | 1 |
Cumming, P; Horsman, MR; Keiding, S; Munk, OL; Sørensen, M | 1 |
Sinesi, MS; Stone, HB | 1 |
Abe, M; Hamanaka, D; Hiraoka, M; Nishidai, T; Ono, K; Takahashi, M | 1 |
Begg, AC; Terry, NH | 1 |
Tsukiyama, I | 1 |
Chapman, JD | 1 |
Rockwell, S | 1 |
Abe, M; Dodo, Y; Nishidai, T; Ono, K; Takahashi, M | 1 |
Mulcahy, RT | 1 |
Brown, DM; Goldfeder, A | 1 |
Irvin, CG; Nierenburg, M; Rockwell, S | 1 |
Yamashita, M | 1 |
Maezawa, H; Mori, T; Murayama, C; Ohizumi, Y | 2 |
Banerjee, R; Goldfeder, A; Mitra, J | 2 |
Lehman, CM; Stewart, JR | 1 |
Chapman, JD; Jette, DC; Wiebe, LI | 1 |
Goldfeder, A | 1 |
Nielsen, OS; Overgaard, J; Overgaard, M; Pedersen, AK; Timothy, AR | 1 |
Gonzalez Gonzalez, D; Haveman, J | 1 |
Breur, K; Haveman, J; Jansen, W; van der Schueren, E | 1 |
Maimonis, P; Michaels, HB; Sedlacek, R; Suit, HD | 1 |
Breur, K; Haveman, J; van den Hoeven, H; van der Schueren, E; Wondergem, J | 1 |
Abe, M; Furunishi, H; Kawanishi, K; Suyama, S; Yabumoto, E; Yamazaki, T | 1 |
Brown, JM | 1 |
Overgaard, J | 1 |
Ash, DV; Smith, MR | 1 |
Abdelaal, AS; Clarke, BM; Wheldon, TE | 1 |
Conroy, PJ; Passalacqua, W; Sutherland, RM | 1 |
Courdi, A; Malaise, EP | 1 |
Twentyman, PR | 1 |
Begg, AC; Brown, JM; Fu, KK; Hurst, S | 1 |
Tannock, IF | 2 |
Franko, AJ; Groebe, K; Gross, MW; Karbach, U; Mueller-Klieser, W | 1 |
Cherif, A; Gretzer, MB; Kim, EE; Li, C; Podoloff, DA; Wallace, S; Yang, DJ | 1 |
Baba, H; Emi, Y; Kusumoto, T; Maehara, Y; Sakaguchi, M; Sakaguchi, Y; Sugimachi, K | 1 |
Cherif, A; Hunter, N; Inoue, T; Kim, EE; Milas, L; Milross, CG; Podoloff, DA; Tansey, W; Wallace, S; Yang, DJ | 1 |
Fujibayashi, Y; Lewis, JS; McCarthy, DW; McCarthy, TJ; Welch, MJ | 1 |
Higuchi, T; Ilgan, S; Kim, EE; Liu, CW; Oh, CS; Podoloff, DA; Yang, DJ; Zareneyrizi, F | 1 |
Chin, LK; Hofstrand, PD; Rasey, JS; Tewson, TJ | 1 |
Bentzen, L; Falborg, L; Hansen, SB; Horsman, MR; Keiding, S; Overgaard, J | 1 |
Brown, JM; Suit, HD | 1 |
Berger, A; Brown, DM; Goldfeder, A | 1 |
Bareham, B; Eddy, HA; Reich, K; Sutherland, RM; Vanantwerp, D | 1 |
Abdelaal, AS; Nias, AH | 1 |
Bridges, JM; Lappin, TR; MacManus, MP; McAleer, JJ; McKeown, SR | 1 |
Grau, C; Mao, HS; Overgaard, J | 1 |
Grau, C; Mao, HS; Overgaard, J; Zachariae, C | 1 |
Bentzen, SM; Grau, C; Overgaard, J | 1 |
Griffiths, JR; Maxwell, RJ; Workman, P | 1 |
Agrawal, KC; McNamara, DB; Shalinsky, DR | 1 |
Denekamp, J; Hill, SA | 1 |
Grierson, JR; Grunbaum, Z; Koh, WJ; Krohn, KA; Rasey, JS | 1 |
Abram, WP; Bridges, JM; MacManus, MP; Maxwell, AP | 1 |
Abe, M; Hori, H; Inayama, S; Kano, E; Ono, K; Shibamoto, Y; Shibata, T; Takahashi, M | 1 |
Harris, JW; Shrieve, DC | 1 |
Epp, ER; Hsieh, CC; Ngo, FQ; Roberts, WK; Sedlacek, R; Silver, G; Suit, HD; Verhey, L | 1 |
Fukuda, H; Hori, H; Inayama, S; Nakajima, T; Onoyama, Y; Sugimoto, K; Tanaka, M | 1 |
Chaplin, DJ; Horsman, MR; Overgaard, J | 1 |
Stone, HB | 1 |
Gipp, JJ; Mulcahy, RT; Tanner, MA | 1 |
Denekamp, J; Randhawa, VS; Rojas, A; Smith, KA; Soranson, JA; Stewart, FA; Stratford, MR | 1 |
Noker, PE; Simpson-Herren, L; Wagoner, SD | 1 |
Sutherland, RM | 1 |
Abe, M; Dodo, Y; Komuro, C; Nishidai, T; Ono, K; Shibamoto, Y; Shrieve, DC; Takahashi, M | 1 |
Hasegawa, R | 1 |
72 other study(ies) available for misonidazole and Experimental Mammary Neoplasms
Article | Year |
---|---|
Hypoxia-selective antitumor agents. 10. bis(nitroimidazoles) and related Bis(nitroheterocycles): development of derivatives with higher rates of metabolic activation under hypoxia and improved aqueous solubility.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cell Hypoxia; Cell Line; Chemical Phenomena; Chemistry, Physical; Cricetinae; Cricetulus; Heterocyclic Compounds; Humans; Mammary Neoplasms, Experimental; Melanoma; Mice; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Solubility; Structure-Activity Relationship; Water | 1995 |
Reproducibility of static and dynamic (18)F-FDG, (18)F-FLT, and (18)F-FMISO MicroPET studies in a murine model of HER2+ breast cancer.
Topics: Animals; Dideoxynucleosides; Female; Fluorodeoxyglucose F18; Humans; Kinetics; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Misonidazole; Models, Biological; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Receptor, ErbB-2; Reproducibility of Results | 2013 |
Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing.
Topics: Animals; Autoradiography; Carbon Dioxide; Cell Hypoxia; Electrodes; Female; Fluorine Radioisotopes; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Oxygen; Tomography, Emission-Computed | 2002 |
Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma.
Topics: Animals; Cell Hypoxia; Female; Fluorine Radioisotopes; Mammary Neoplasms, Experimental; Metabolic Clearance Rate; Mice; Misonidazole; Nitroimidazoles; Organ Specificity; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution | 2004 |
Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors.
Topics: Animals; Autoradiography; Carcinoma, Squamous Cell; Cell Hypoxia; Female; Fluorodeoxyglucose F18; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Oxygen Consumption; Partial Pressure; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals | 2005 |
Testing of new hypoxic cell sensitizers in vivo.
Topics: Animals; Drug Evaluation, Preclinical; Etanidazole; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1982 |
[Studies in radiosensitizing effects of misonidazole and SR-2508 on experimental animal tumors].
Topics: Animals; Etanidazole; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1983 |
Modification of stromal radiosensitivity by misonidazole and WR-2721.
Topics: Adenocarcinoma; Amifostine; Animals; Connective Tissue; Dose-Response Relationship, Radiation; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Organothiophosphorus Compounds; Radiation Tolerance | 1983 |
[Combined use of amifostine and misonidazole in experimental radiotherapy].
Topics: Amifostine; Animals; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Organothiophosphorus Compounds; Radiation-Protective Agents | 1983 |
The detection and measurement of hypoxic cells in solid tumors.
Topics: Anaerobiosis; Animals; Brain Neoplasms; Carbon Radioisotopes; Cell Line; Cell Survival; Cricetinae; Cricetulus; Humans; Hypoxia; Lung; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Misonidazole; Neoplasms; Radiation-Sensitizing Agents; Rats; Tomography, Emission-Computed | 1984 |
Combination therapy with misonidazole and mitomycin C: lack of chemosensitization of EMT6 tumor cells in vivo or in vitro.
Topics: Animals; Antibiotics, Antineoplastic; Cell Survival; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Mitomycin; Mitomycins; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Time Factors | 1984 |
[The effect of diethyl maleate (DEM) on the radiosensitization by misonidazole (MISO) in experimental animal tumors].
Topics: Animals; Drug Synergism; Maleates; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Effect of oxygen on misonidazole chemosensitization and cytotoxicity in vitro.
Topics: Aerobiosis; Animals; Cell Line; Cell Survival; Kinetics; Lomustine; Mammary Neoplasms, Experimental; Mice; Misonidazole; Nitroimidazoles; Oxygen | 1984 |
Response of an experimental mammary carcinoma to fractionated X-irradiation with misonidazole and microwave hyperthermia.
Topics: Adenocarcinoma; Animals; Combined Modality Therapy; Diathermy; Female; Mammary Neoplasms, Experimental; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Enhancement of artificial lung metastases by misonidazole.
Topics: Animals; Cell Line; Female; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents | 1984 |
Radiosensitizing effect of combined radiotherapy, hyperthermia and misonidazole on C3H mouse FM3A tumor.
Topics: Animals; Cell Line; Combined Modality Therapy; Female; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles | 1984 |
The effect of hypoxic radiosensitizer after mild hyperthermia in C3H mammary carcinoma.
Topics: Anaerobiosis; Animals; Combined Modality Therapy; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1984 |
Polarographic measurement of misonidazole in mouse mammary tumors.
Topics: Animals; Half-Life; Hypoxia; In Vitro Techniques; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Polarography; Tissue Distribution | 1984 |
Sister chromatid exchanges and chromosome aberrations induced by radiosensitizing agents in bone marrow cells of treated tumor-bearing mice.
Topics: Animals; Bone Marrow; Cell Line; Chromosome Aberrations; Crossing Over, Genetic; Hot Temperature; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Microwaves; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiotherapy Dosage; Sister Chromatid Exchange | 1983 |
In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
Topics: Animals; Drug Evaluation, Preclinical; Female; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Temperature; Time Factors | 1983 |
Synthesis and in vivo studies of the radiosensitizer 4-[82Br]bromomisonidazole.
Topics: Animals; Bromine; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiation-Sensitizing Agents; Radioisotopes; Radionuclide Imaging; Tissue Distribution | 1983 |
Combined effects of misonidazole, microwave hyperthermia, and X-rays on the in vivo sister chromatid exchanges and chromosomal abnormalities of the dbrB tumor and on the survival of its host.
Topics: Adenocarcinoma; Animals; Chromosome Aberrations; Crossing Over, Genetic; Female; Hot Temperature; Karyotyping; Mammary Neoplasms, Experimental; Mice; Microwaves; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Radiotherapy Dosage; Sister Chromatid Exchange; Time Factors; X-Rays | 1983 |
Cell kinetics, cell structure, and radiotherapy.
Topics: Adenocarcinoma; Animals; Cell Division; Cell Line; Computers; Female; Hot Temperature; Lymphoma; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Microscopy, Electron; Misonidazole; Sarcoma, Experimental | 1982 |
A comparative investigation of nimorazole and misonidazole as hypoxic radiosensitizers in a C3H mammary carcinoma in vivo.
Topics: Animals; Cell Survival; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Female; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Misonidazole; Nimorazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1982 |
Effects of irradiation by single or multiple fractions per day on transplantable murine mammary carcinoma.
Topics: Adenocarcinoma; Animals; Dactinomycin; Dose-Response Relationship, Radiation; Male; Mammary Neoplasms, Experimental; Mice; Misonidazole; Neoplasm Transplantation; Radiotherapy Dosage; Time Factors | 1982 |
Radiosensitivity of microscopic tumours of a transplantable mammary adenocarcinoma in mice.
Topics: Adenocarcinoma; Animals; Cell Count; Cell Survival; Dose-Response Relationship, Radiation; Mammary Neoplasms, Experimental; Mice; Misonidazole; Neoplasm Transplantation; Radiation Tolerance; Transplantation, Homologous | 1981 |
Comparison of hyperbaric oxygen and misonidazole in fractionated irradiation of murine tumors.
Topics: Animals; Carcinoma, Squamous Cell; Female; Hyperbaric Oxygenation; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Skin | 1981 |
The influence of misonidazole on the radiation response of murine tumors of different size: possible artifacts caused by pentobarbital sodium anesthesia.
Topics: Adenocarcinoma; Anesthesia; Animals; Dose-Response Relationship, Radiation; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Pentobarbital; Radiation-Protective Agents | 1981 |
[Radiosensitization of C3H/He mammary carcinoma by administration of hyperthermia and/or of misonidazole (author's transl)].
Topics: Animals; Female; Hot Temperature; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy Dosage | 1981 |
Radiosensitizers: rationale and potential.
Topics: Animals; Cell Survival; Female; Humans; Kinetics; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Neoplasms; Radiation-Sensitizing Agents; Structure-Activity Relationship | 1981 |
Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
Topics: Animals; Dose-Response Relationship, Drug; Female; Hot Temperature; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Radiation Tolerance; Skin; Time Factors | 1980 |
Causes of apparent low levels of misonidazole in human tumours.
Topics: Adipose Tissue; Animals; Brain Neoplasms; Humans; In Vitro Techniques; Liver Neoplasms; Mammary Neoplasms, Experimental; Mice; Misonidazole; Muscles; Neoplasms; Nitroimidazoles; Rats | 1980 |
Perturbation of the growth kinetics of C3H mouse mammary carcinoma by irradiation of tumour and host and by attempted pre-immunization of host.
Topics: Adenocarcinoma; Animals; Dose-Response Relationship, Radiation; Immunization; Mammary Neoplasms, Experimental; Mice; Misonidazole; Neoplasm Recurrence, Local; Neoplasm Transplantation; Time Factors; Transplantation, Homologous | 1980 |
Misonidazole cytotoxicity in vivo: a comparison of large single doses with smaller doses and extended contact of the drug with tumor cells.
Topics: Animals; Body Temperature; Dose-Response Relationship, Drug; Infusions, Parenteral; Injections, Intraperitoneal; Kinetics; Mammary Neoplasms, Experimental; Mice; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Oxygen; Time Factors; Transplantation, Homologous | 1980 |
Effect of size of lymph node metastases on the radiation response: influence of misonidazole.
Topics: Animals; Cell Count; Female; Gamma Rays; Injections, Intraperitoneal; Lymph Nodes; Lymphatic Metastasis; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Misonidazole; Nitroimidazoles; Organ Size; Time Factors | 1980 |
The response of EMT6 tumor spheroids to combined treatment with misonidazole and either nitrogen mustard, adriamycin, or BCNU.
Topics: Animals; Antineoplastic Agents; Carmustine; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; In Vitro Techniques; Mammary Neoplasms, Experimental; Mechlorethamine; Mice; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1980 |
The effects of misonidazole during continuous low dose rate irradiation.
Topics: Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Half-Life; Injections, Intraperitoneal; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents | 1980 |
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin.
Topics: Animals; Body Weight; Doxorubicin; Drug Therapy, Combination; Fibrosarcoma; Fluorouracil; Leukocyte Count; Male; Mammary Neoplasms, Experimental; Methotrexate; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1980 |
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
Topics: Animals; Body Weight; Carmustine; Cyclophosphamide; Drug Therapy, Combination; Fibrosarcoma; Leukocyte Count; Male; Mammary Neoplasms, Experimental; Metronidazole; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles; Sarcoma, Experimental | 1980 |
Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids.
Topics: Animals; Autoradiography; Calibration; Cell Division; Cell Hypoxia; Feasibility Studies; Mammary Neoplasms, Experimental; Mice; Microelectrodes; Misonidazole; Oxygen; Partial Pressure; Tritium; Tumor Cells, Cultured | 1995 |
Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia.
Topics: Animals; Autoradiography; Cell Hypoxia; Contrast Media; Female; Fluorine Radioisotopes; Male; Mammary Neoplasms, Experimental; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Rabbits; Rats; Rats, Inbred F344; Tissue Distribution; Tomography, Emission-Computed | 1995 |
Effect of hyperthermia on the activity of 1-[(4'-hydroxy-2'-butenoxy)methyl]-2-nitroimidazole, which is cytotoxic to hypoxic cells.
Topics: Animals; Cell Hypoxia; Cell Survival; Combined Modality Therapy; Dose-Response Relationship, Drug; Female; Hyperthermia, Induced; Mammary Neoplasms, Experimental; Mice; Misonidazole; Radiation-Sensitizing Agents; Time Factors; Tumor Cells, Cultured | 1993 |
Evaluation of [131I]iodoerythronitroimidazole as a predictor for the radiosensitizing effect.
Topics: Animals; Cell Transplantation; Female; Iodine Radioisotopes; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Predictive Value of Tests; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tumor Cells, Cultured | 1996 |
Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
Topics: Animals; Autoradiography; Cell Hypoxia; Coordination Complexes; Drug Evaluation, Preclinical; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Organometallic Compounds; Oxygen; Thiosemicarbazones; Tissue Distribution; Tumor Cells, Cultured | 1999 |
Noninvasive assessment of tumor hypoxia with 99mTc labeled metronidazole.
Topics: Animals; Autoradiography; Cell Hypoxia; Cysteine; Female; Fluorine Radioisotopes; Iodine Radioisotopes; Mammary Neoplasms, Experimental; Metronidazole; Microelectrodes; Misonidazole; Neovascularization, Pathologic; Organotechnetium Compounds; Oxygen; Radiation-Sensitizing Agents; Radionuclide Imaging; Rats; Rats, Inbred F344; Tissue Distribution | 1999 |
Characterization of [18F]fluoroetanidazole, a new radiopharmaceutical for detecting tumor hypoxia.
Topics: Animals; Binding Sites; Blood-Brain Barrier; Cell Hypoxia; Chromatography, High Pressure Liquid; Contrast Media; Cricetinae; Cricetulus; Etanidazole; Female; Fibroblasts; Fibrosarcoma; Fluorine Radioisotopes; Glioma; Lung; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasms, Experimental; Oxygen; Radionuclide Imaging; Radiopharmaceuticals; Rats; Sarcoma, Experimental; Time Factors; Tissue Distribution; Tumor Cells, Cultured | 1999 |
Feasibility of detecting hypoxia in experimental mouse tumours with 18F-fluorinated tracers and positron emission tomography--a study evaluating [18F]Fluoro-2-deoxy-D-glucose.
Topics: Animals; Binding Sites; Carbon Dioxide; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Hypoxia; Mammary Neoplasms, Experimental; Mice; Misonidazole; Oxygen; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tomography, Emission-Computed | 2000 |
Relative efficacy of high-pressure oxygen and misonidazole to reduce TCD50 of a mouse mammary carcinoma.
Topics: Animals; Hyperbaric Oxygenation; Lethal Dose 50; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Nitroimidazoles | 1979 |
Enhancement of radioresponse of a mouse mammary carcinoma to combined treatments with hyperthermia and radiosensitizer misonidazole.
Topics: Adenocarcinoma; Animals; Hot Temperature; Male; Mammary Neoplasms, Experimental; Mice; Misonidazole; Nitroimidazoles; Radiation Tolerance; Remission, Spontaneous; Time Factors; X-Rays | 1979 |
Resistance to adriamycin in multicellular spheroids.
Topics: Animals; Cell Division; Cell Survival; Cells, Cultured; Doxorubicin; Drug Resistance; Female; Hypoxia; Mammary Neoplasms, Experimental; Mice; Misonidazole | 1979 |
Regression, recurrence and cure in an irradiated mouse tumour.
Topics: Animals; Dose-Response Relationship, Radiation; Female; Male; Mammary Neoplasms, Experimental; Mice; Misonidazole; Neoplasm Recurrence, Local; Neoplasms; Time Factors | 1979 |
Hypobaric hypoxia: a method for testing bioreductive drugs in vivo.
Topics: Animals; Biotransformation; Cell Hypoxia; Dose-Response Relationship, Drug; Mammary Neoplasms, Experimental; Mechlorethamine; Mice; Mice, Inbred Strains; Misonidazole; Radiation-Sensitizing Agents; Tirapazamine; Triazines | 1992 |
Interaction of misonidazole, hyperthermia, and irradiation in a C3H mammary carcinoma and its surrounding skin in vivo.
Topics: Animals; Combined Modality Therapy; Feasibility Studies; Female; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Misonidazole; Skin | 1992 |
The in vivo response of a C3H mammary carcinoma to treatment with misonidazole, cyclophosphamide and radiation.
Topics: Animals; Cell Division; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Interactions; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Time Factors | 1990 |
Cytotoxic effect of misonidazole and cyclophosphamide on aerobic and hypoxic cells in a C3H mammary carcinoma in vivo.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cyclophosphamide; Male; Mammary Neoplasms, Experimental; Mice; Misonidazole; Oxygen | 1990 |
Demonstration of tumor-selective retention of fluorinated nitroimidazole probes by 19F magnetic resonance spectroscopy in vivo.
Topics: Animals; Magnetic Resonance Spectroscopy; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Neoplasms, Experimental; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Sarcoma, Experimental | 1989 |
Modulation of prostaglandin biosynthesis in hypoxic murine mammary adenocarcinoma cells by misonidazole.
Topics: Adenocarcinoma; Anaerobiosis; Animals; Cell Line; Hypoxia; Indomethacin; Kinetics; Lung Neoplasms; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Prostaglandins; Tumor Cells, Cultured | 1989 |
An experimental study of tumour size and radiosensitivity: analysis by regrowth delay.
Topics: Animals; Dose-Response Relationship, Radiation; Female; Mammary Neoplasms, Experimental; Mice; Misonidazole; Radiation Tolerance; Radiotherapy Dosage | 1989 |
Radiolabelled fluoromisonidazole as an imaging agent for tumor hypoxia.
Topics: Adenocarcinoma; Animals; Bone Neoplasms; Cell Hypoxia; Cells, Cultured; Contrast Media; Cricetinae; Cricetulus; Dogs; Fibroblasts; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Misonidazole; Osteosarcoma; Radiation Tolerance; Radionuclide Imaging; Sarcoma, Experimental | 1989 |
The effect of hypobaric hypoxia on misonidazole binding in normal and tumour-bearing mice.
Topics: Air Pressure; Animals; Atmospheric Pressure; Autoradiography; Kidney; Liver; Male; Mammary Neoplasms, Experimental; Mice; Misonidazole; Oxygen; Scintillation Counting | 1989 |
An in vitro and in vivo screening system for new hypoxic cell radiosensitizers using EMT6 cells.
Topics: Animals; Cell Line; Cell Survival; Dose-Response Relationship, Radiation; Drug Evaluation, Preclinical; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Misonidazole; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents; Tetrazoles | 1986 |
The in vitro sensitivity of chronically hypoxic EMT6/SF cells to X-radiation and hypoxic cell radiosensitizers.
Topics: Animals; Cell Line; Cell Survival; Cells, Cultured; Etanidazole; Female; Mammary Neoplasms, Experimental; Mice; Misonidazole; Nitroimidazoles; Oxygen; Radiation Tolerance; Radiation-Sensitizing Agents; Rats; Sulfhydryl Compounds; X-Rays | 1985 |
Therapeutic gain factors for fractionated radiation treatment of spontaneous murine tumors using fast neutrons, photons plus O2(1) or 3 ATA, or photons plus misonidazole.
Topics: Animals; Carcinoma, Squamous Cell; Combined Modality Therapy; Fast Neutrons; Female; Fibrosarcoma; Hyperbaric Oxygenation; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Oxygen; Radiotherapy Dosage | 1988 |
[Radiosensitizing effect of the nitroimidazole derivatives RK28 and DNIE on murine tumors].
Topics: Animals; Chemical Phenomena; Chemistry; Drug Evaluation; Lethal Dose 50; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Neoplasm Transplantation; Nitroimidazoles; Rabbits; Radiation-Sensitizing Agents | 1988 |
The interaction between RSU-1069, hydralazine and hyperthermia in a C3H mammary carcinoma as assessed by tumour growth delay.
Topics: Animals; Combined Modality Therapy; Female; Hydralazine; Hyperthermia, Induced; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Mice, Inbred DBA; Misonidazole | 1988 |
Misonidazole in fractionated radiotherapy of a murine mammary carcinoma: comparison of tumor and normal tissue response.
Topics: Animals; Female; Mammary Neoplasms, Experimental; Mice; Misonidazole; Muscle Contraction; Radiotherapy Dosage | 1988 |
Enhancement of misonidazole chemopotentiation by mild hyperthermia (41 degrees C) in vitro and selective enhancement in vivo.
Topics: Aerobiosis; Animals; Cell Line; Combined Modality Therapy; Drug Synergism; Female; Hot Temperature; Hyperthermia, Induced; Lomustine; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Oxygen; Sarcoma, Experimental | 1987 |
Effect of anemia on tumor radiosensitivity under normo and hyperbaric conditions.
Topics: Adenocarcinoma; Air; Anemia; Animals; Blood Transfusion; Chronic Disease; Female; Hyperbaric Oxygenation; Kidney; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred CBA; Misonidazole; Radiation Tolerance; Radiotherapy Dosage; Time Factors | 1987 |
Distribution of nitroimidazoles and L-phenylalanine mustard in mammary adenocarcinoma 16/C tumors.
Topics: Adenocarcinoma; Animals; Female; Lissamine Green Dyes; Mammary Neoplasms, Experimental; Melphalan; Metronidazole; Mice; Misonidazole; Nitroimidazoles; Time Factors | 1987 |
Importance of critical metabolites and cellular interactions in the biology of microregions of tumors.
Topics: Adenocarcinoma; Animals; Cell Communication; Cell Cycle; Culture Techniques; Glucose; Humans; Intestinal Mucosa; Mammary Neoplasms, Experimental; Misonidazole; Neoplasms; Oxygen; Oxyhemoglobins; Rectal Neoplasms | 1986 |
The radiosensitizing effects of misonidazole (MISO) in combination with diethyl maleate (DEM) in mouse mammary tumors.
Topics: Animals; Combined Modality Therapy; Drug Therapy, Combination; Female; Maleates; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole; Radiation-Sensitizing Agents | 1986 |
[The radiosensitizing effects of misonidazole and/or 5FU on C3H mouse mammary carcinoma].
Topics: Animals; Combined Modality Therapy; Female; Fluorouracil; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C3H; Misonidazole | 1985 |